Avalo Therapeutics Inc. (AVTX)
NASDAQ: AVTX
· Real-Time Price · USD
4.65
-0.19 (-3.93%)
At close: Jun 16, 2025, 3:59 PM
4.75
2.15%
Pre-market: Jun 17, 2025, 08:00 AM EDT
-3.93% (1D)
| Bid | 4.52 |
| Market Cap | 50.35M |
| Revenue (ttm) | 441K |
| Net Income (ttm) | 73.01M |
| EPS (ttm) | 118.98 |
| PE Ratio (ttm) | 0.04 |
| Forward PE | -0.99 |
| Analyst | Buy |
| Ask | 4.98 |
| Volume | 26,730 |
| Avg. Volume (20D) | 71,279 |
| Open | 4.89 |
| Previous Close | 4.84 |
| Day's Range | 4.65 - 4.89 |
| 52-Week Range | 3.39 - 16.00 |
| Beta | 0.71 |
About AVTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AVTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AVTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+11.93%
Avalo Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
9 months ago
+8.88%
Avalo Therapeutics shares are trading higher after BVF Partners disclosed in a 13G filing that it reported a 9.99% stake in the company.
